We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Elevated serum ACE levels in patients with post-acute COVID-19 syndrome.
- Authors
Mitchell, P D; Buckley, C; Subramaniam, A; Crowther, S; Donnelly, S C
- Abstract
We postulate that in those patients who developed long COVID syndrome along with an elevated serum ACE level may have developed an aberrant longer-term immune response to COVID infection. The serum ACE was elevated at 121 µ/l - normal 0-65 µ/l. The chest CT scan performed 5 months after the patients' acute COVID infection demonstrated extensive bilateral subpleural peripheral dense consolidation throughout both lungs. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the current coronavirus disease (COVID-19) pandemic.[1] Over recent months, a plethora of novel research articles has been published, dealing with multiple aspects and manifestations of both the acute disease and its longer-term sequelae.
- Subjects
POST-acute COVID-19 syndrome; COVID-19; SARS-CoV-2; SARCOIDOSIS; CORONAVIRUS diseases
- Publication
QJM: An International Journal of Medicine, 2022, Vol 115, Issue 10, p651
- ISSN
1460-2725
- Publication type
Article
- DOI
10.1093/qjmed/hcac119